TOKYO -- Takeda Pharmaceutical and two Japanese universities are developing a drug to treat the clogging and inflammation of blood vessels, complications of COVID-19.
The drug uses a mechanism different from those of existing coronavirus drugs, and the developers report that it will likely help prevent the aggravation of COVID-19 symptoms.
